Mohammed Alrouji

Shaqra', Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Correction: CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders.

Correction: CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders.

Journal: Frontiers in cellular neuroscience

Published: November 05, 2025

CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders.

CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders.

Journal: Frontiers in cellular neuroscience

Published: August 08, 2025

Computational screening of repurposed drugs targeting lactoferrin for neurodegenerative diseases.

Computational screening of repurposed drugs targeting lactoferrin for neurodegenerative diseases.

Journal: Journal of Alzheimer's disease : JAD

Published: July 18, 2025

Computational drug repurposing reveals Alectinib as a potential lead targeting Cathepsin S for therapeutic developments against cancer and chronic pain.

Computational drug repurposing reveals Alectinib as a potential lead targeting Cathepsin S for therapeutic developments against cancer and chronic pain.

Journal: Frontiers in bioinformatics

Published: July 15, 2025

Interplay Between Aging and Tau Pathology in Alzheimer's Disease: Mechanisms and Translational Perspectives.

Interplay Between Aging and Tau Pathology in Alzheimer's Disease: Mechanisms and Translational Perspectives.

Journal: Antioxidants (Basel, Switzerland)

Published: April 28, 2025

Mechanistic Roles of Transcriptional Cyclin-Dependent Kinases in Oncogenesis: Implications for Cancer Therapy.

Mechanistic Roles of Transcriptional Cyclin-Dependent Kinases in Oncogenesis: Implications for Cancer Therapy.

Journal: Cancers

Published: March 07, 2025

Unraveling human transferrin-tryptamine interactions: a computational and biophysical approach to Alzheimer's disease therapeutics.

Unraveling human transferrin-tryptamine interactions: a computational and biophysical approach to Alzheimer's disease therapeutics.

Journal: Frontiers in pharmacology

Published: December 06, 2024

Molecular Signaling Pathways of Quercetin in Alzheimer's Disease: A Promising Arena.

Molecular Signaling Pathways of Quercetin in Alzheimer's Disease: A Promising Arena.

Journal: Cellular and molecular neurobiology

Published: November 12, 2024

Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery.

Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery.

Journal: Journal of cellular and molecular medicine

Published: October 31, 2024

The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke.

The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke.

Journal: Brain research bulletin

Published: October 12, 2024

Employing spectroscopic, calorimetric and structural bioinformatics approaches to decipher the binding mechanism of mangiferin with human transferrin.

Employing spectroscopic, calorimetric and structural bioinformatics approaches to decipher the binding mechanism of mangiferin with human transferrin.

Journal: International journal of biological macromolecules

Published: September 29, 2024

Repurposed drugs as histone deacetylase 8 inhibitors: Implications in cancer and neuropathological conditions.

Repurposed drugs as histone deacetylase 8 inhibitors: Implications in cancer and neuropathological conditions.

Journal: Frontiers in pharmacology

Published: August 30, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026